メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
飯塚 勝美
医学部・臨床栄養学
h-index
2721
被引用数
24
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1996 …
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(82)
類似のプロファイル
(6)
フィンガープリント
Katsumi Iizukaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Biochemistry, Genetics and Molecular Biology
Response Element
100%
Binding Protein
100%
Mouse
58%
Transcription Factors
45%
Messenger RNA
45%
Lipogenesis
40%
Lipid Metabolism
38%
Glucose Blood Level
29%
Enzyme
27%
Autoantibodies
27%
Glucagon
26%
Glucose 6-Phosphatase
25%
Hepatocyte
24%
Glucose Metabolism
21%
Gene Expression
21%
Glycated Hemoglobin
18%
Triglyceride
17%
Glucose Level
17%
Albumin Level
16%
Genetics
16%
Genetic Screening
16%
Gene Mutation
16%
Glucokinase
15%
FGF21
15%
Gastric Inhibitory Polypeptide
15%
Lipoprotein Secretion
14%
Very Low-Density Lipoprotein
13%
Glucagon-Like Peptide-1
13%
Glucose Test
13%
Glucose Tolerance Test
13%
Glomerulus Filtration
12%
High-Performance Liquid Chromatography
12%
Receptor Agonists
12%
Insulin Analog
12%
Immunoprecipitation
12%
Ob/Ob Mouse
12%
Liraglutide
12%
Glucagon Receptor
12%
Tumor Progression
12%
Kidney Function
12%
Enzyme Active Site
12%
Hemoglobins
12%
Intestine Flora
12%
Insulin Release
12%
Leptin
12%
Klinefelter Syndrome
12%
Glucagon-Like Peptide 1 Receptor
12%
Prednisolone
12%
C57BL 6 Mouse
12%
Protamine
12%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
55%
Protein Binding
37%
DNA Responsive Element
37%
Patient with Type 2 Diabetes
37%
Glucagon Like Peptide 1
30%
Liraglutide
25%
Insulin Glargine Plus Lixisenatide
25%
Hyperglycemia
25%
Hepatocyte
16%
Autoantibodies
15%
Meal
15%
Hypothalamus
15%
Glucagon-Like Peptide-1 Agonist
13%
Hemoglobin Variant
12%
Substrate Utilization
12%
Thymus Hyperplasia
12%
Glucose Tolerance
12%
Thyroid Function
12%
Calcium Sensing
12%
Glomerular Filtration Rate
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
FGF21
12%
Post-Hoc Analysis
12%
Primary Central Nervous System Lymphoma
12%
Hypoglycemic Coma
12%
Sucrose Intolerance
12%
Combination Therapy
12%
Klinefelter Syndrome
12%
Secretion (Process)
12%
Graves' Disease
12%
Bicornuate Uterus
12%
Kidney Function
12%
Thyrotropin Receptor
12%
Genetic Transcription
12%
Thiamazole
12%
Lipogenesis
12%
Western Diet
12%
Hemoglobin A1c
9%
Sodium Glucose Cotransporter 2
8%
Diabetes
8%
Postprandial Hyperglycemia
7%
Magnetic Resonance Imaging
7%
Transcription Factors
7%
C-Peptide
6%
Glycated Hemoglobin
6%
Proinsulin
6%
Liquid Chromatography
6%
Fatty Acid
6%
Lipid Metabolism
6%
Miglitol
6%
Keyphrases
ChREBP
30%
Rat Hepatocytes
14%
Dominant Negative
14%
Protein Activation
12%
Hypoxia-inducible factor-1α (HIF-1α)
12%
Glycated Albumin
12%
C57BL
12%
Substrate Utilization
12%
Metabolic Consequences
12%
MRNA Expression
12%
Retrospective Observational Study
12%
Calcium Sensing
12%
Sensing Ability
12%
Entry Blocker
12%
IGlarLixi
12%
Cinderella
12%
Vitamin Deficiency
12%
Glucagon Receptor
12%
Underweight Women
12%
Thymic Size
12%
Fibroblast Growth Factor 21 (FGF21)
12%
GLP-1 Analogue
12%
Albumin Level
12%
Hypoglycemic Coma
12%
Steroid-induced Diabetes Mellitus
12%
LixiLan
12%
Lipid Metabolism Regulation
12%
Primary Hypoparathyroidism
12%
Autoimmune Polyglandular Syndrome
12%
Calpain-10
12%
Overexpression
12%
High Dose
12%
Diabetes
12%
Circulating Lipids
12%
Fructose Malabsorption
12%
Klinefelter Syndrome
12%
Protein O-glycosylation
12%
Fiber Composition
12%
Metabolic Profiling
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Genetic Variation
12%
HNF1B Gene
12%
Glycemic Control
12%
Food Recording
12%
Liver Receptor homologue-1 (LRH-1)
12%
GLP-1 Receptor Agonist
12%
Glucose Sensitivity
12%
Artificial Sweeteners
12%
Insulin Autoantibodies
12%
KLF11
12%
